This study is completed in Norway. It is testing D-Cycloserine for OCD.
OCDDrugOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether a digital tool or app may be useful for adults experiencing ocd.
What would participation involve?
Participants may use a digital tool or app, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Norway.
Who is it mainly for?
This study appears to be mainly for adults with ocd.
What should you check before joining?
Ask about whether participation can be remote and what device access is needed, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: November 2015
Recruitment status
Completed
Enrollment listed in the registry
163
Sponsor
Haukeland University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Norway
Age range
Over 18 Years
Official registry ID
NCT02656342
Official title
Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients? A Randomized, Double-blind, Placebo-controlled National Study
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT02656342. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Norway · 14 sites
Haukeland University Hospital
Bergen
Site status: Not listed — confirm with the team
Innlandet Hospital
Brumunddal
Site status: Not listed — confirm with the team
Forde Hospital
Førde
Site status: Not listed — confirm with the team
Sørlandet Hospital
Kristiansand
Site status: Not listed — confirm with the team
Nord Trøndelag Hospital
Levanger
Site status: Not listed — confirm with the team
Akershus University Hospital
Lorenskog
Site status: Not listed — confirm with the team
More and Romsdal Hospital
Molde
Site status: Not listed — confirm with the team
Østfold Hospital
Moss
Site status: Not listed — confirm with the team
Oslo University Hospital
Oslo
Site status: Not listed — confirm with the team
Vestre Viken
Sandvika
Site status: Not listed — confirm with the team
Stavanger University Hospital
Stavanger
Site status: Not listed — confirm with the team
Tromso University Hospital
Tromsø
Site status: Not listed — confirm with the team
St. Olavs Hospital
Trondheim
Site status: Not listed — confirm with the team
Sykehuset i Vestfold
Tønsberg
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with ocd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving D-Cycloserine, Placebo. Phase 4 studies usually happen after treatment approval, to monitor real-world use.
Who might this study be for?
This study may concern people with ocd; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Will I need to change, stop, or stabilize my current treatment?
The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Haukeland University Hospital, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
